October 19, 2022
Via: Contract PharmaAyala Pharmaceuticals, Inc., a clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers, and Advaxis, Inc., a biotechnology company developing immunotherapies engineered using Listeria monocytogenes, have entered into a definitive merger agreement. The merger would result […]
July 19, 2024
July 11, 2024
July 11, 2024